Mediterranean diet intervention may not improve breast cancer prognosis in high-risk patients Post author: Post published:October 20, 2023 Post category:uncategorized Researchers discuss the results of a randomized controlled trial to explore the impact of diet on breast cancer recurrence. You Might Also Like Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025 April 1, 2025 CBL identified as the most promising potential biomarker for aortic dissection August 29, 2024 Study reveals alarming rates of postpartum depression among mothers in six countries May 19, 2024
Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025 April 1, 2025